Latest LH news

Labcorp: The CMS Selloff Represents An Excellent Opportunity - Strong Buy

Seeking Alpha · Wed, 23 Sep 2026 14:58:12 -0400

Labcorp shares dropped sharply after CMS released preliminary 2027 lab-payment rates, aligning Medicare rates closer to private insurers and targeting $1B annual savings. I see the selloff as overdone, with market fears exaggerated by a misunderstanding of the CMS report's impact on LH's bottom line. The proposed cuts only affect Medicare's Clinical Laboratory Fee Schedule, with annual reimbursement reductions capped at 15% and final rates pending.

Labcorp's Future Driven By Clinical Testing Demand, Despite Impact From Medicare Cuts

Seeking Alpha · Tue, 22 Sep 2026 17:53:49 -0400

Labcorp Holdings Inc. is upgraded to Buy, supported by resilient demand for diagnostics and robust Q2 results, despite upcoming Medicare rate cuts. LH outperformed both the S&P 500 and healthcare peers YTD, with strong technical support and positive operating margins. Revenue durability, new test launches, and a diversified biopharma segment bolster LH's growth and risk profile amid regulatory headwinds.

Why Labcorp Holdings Stock Dropped Today

The Motley Fool · Tue, 22 Sep 2026 11:24:09 -0400

Medicare and Medicaid have been overpaying Labcorp for years, says the government. Starting next year, they plan to cut reimbursement of lab testing by 15%.

Labcorp Holdings Inc. (LH) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

Seeking Alpha · Tue, 15 Sep 2026 14:31:38 -0400

Labcorp Holdings Inc. (LH) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

Labcorp Holdings Inc. (LH) Analyst/Investor Day Transcript

Seeking Alpha · Fri, 11 Sep 2026 04:17:05 -0400

Labcorp Holdings Inc. (LH) Analyst/Investor Day Transcript

Labcorp Bets Big on AI, Specialty Testing to Drive Growth Through 2029

Benzinga · Thu, 10 Sep 2026 13:40:03 -0400

Labcorp Holdings (NYSE:LH) on Thursday presented a comprehensive growth strategy and long-term financial forecast during its 2026 Investor Day.

Labcorp Highlights Strategic Priorities Driving Durable Growth and Shareholder Value at 2026 Investor Day

PRNewsWire · Thu, 10 Sep 2026 07:00:00 -0400

Reaffirms full-year 2026 guidance Provides long-term outlook through 2029, with compound annual revenue growth of 5% to 8% and compound annual adjusted earnings per share (EPS) growth of 8.5% to 11.5% Outlines strategic growth priorities driven by a differentiated platform powered by science, technology and global scale Presents long-term value creation framework driven by sustainable growth, strong cash flow generation and disciplined capital deployment BURLINGTON, N.C., Sept. 10, 2026 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today will host its 2026 Investor Day at 9 a.m.

Market information is provided for research and visualization and is not investment advice.